- 专利标题: FUSED HETEROCYCLIC COMPOUND
-
申请号: US15561613申请日: 2016-03-25
-
公开(公告)号: US20180072694A1公开(公告)日: 2018-03-15
- 发明人: Keiko Kakegawa , Zenichi IKEDA , Minoru SASAKI , Fumiaki KIKUCHI , Yoichi NISHIKAWA
- 申请人: Takeda Pharmaceutical Company Limited
- 申请人地址: JP Chuo-ku, Osaka-shi, Osaka
- 专利权人: Takeda Pharmaceutical Company Limited
- 当前专利权人: Takeda Pharmaceutical Company Limited
- 当前专利权人地址: JP Chuo-ku, Osaka-shi, Osaka
- 优先权: JP2015-066622 20150327
- 国际申请: PCT/JP2016/059705 WO 20160325
- 主分类号: C07D307/79
- IPC分类号: C07D307/79 ; C07D413/04 ; C07F9/655
摘要:
The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like. Specifically, the present invention relates to a compound represented by the formula (I) or a salt thereof, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like [in the formula, each symbol is as defined in the specification].
公开/授权文献
- US10017487B2 Fused heterocyclic compound 公开/授权日:2018-07-10